Stock research
ADIA Adia Med Inc.
Healthcare • Medical - Pharmaceuticals
Adia Med Inc. is a publicly traded company dedicated to advancing regenerative medicine and healthcare innovation. The company operates through its primary divisions: Adia Med clinics and Adia Labs LLC. Adia Med...…
Adia Med Inc. is a publicly traded company dedicated to advancing regenerative medicine and healthcare innovation. The company operates through its primary divisions: Adia Med clinics and Adia Labs LLC. Adia Med clinics deliver specialized regenerative treatments, including stem cell therapies, while Adia Labs manufactures and distributes regenerative products. The company is also involved in multiple Institutional Review Board (IRB)-approved clinical studies.
5Y change
+3233.33%
Range high
$0.24
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in ADIA?
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $0.13
- Day High
- $0.13
- Day Low
- $0.13
- 52w High
- $0.28
- 52w Low
- $0.03
- Volume
- 192
- Avg Volume
- Beta
- -8.433
* TTM/most recent where available
Company
- Ticker
- ADIA
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Country
- US
- CEO
- Larry Powalisz
- Employees
- 3
- Website
- www.adianutrition.com
Key Metrics
- Market Cap
- 12.3M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).